News for hackers. Stuff that matters.
Re:Biohackers take aim at big pharma’s stranglehold on insulin by Natsu on Tuesday June 29, 2021 @11:14AM (#27677009)
I think the problem is that this isn't in either of their interests. The insurers benefit from high prices because it scares people into staying insured and, IIRC, the laws limit the percentage of their profits, so a percentage of a higher number means more profit. The drug companies more obviously benefit from high prices.

There are no comments on this comment yet.